NOV 18, 2021 6:30 AM PST

Sequencing and AI Combo Powers Up ADHD Diagnostics

WRITTEN BY: Tara Fernandez

Attention-deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders. Red flags signaling the condition are often picked up during childhood when children experience problems paying attention or controlling impulsive behaviors. 

Diagnosing ADHD is not straightforward. Without a single test to positively identify the condition, children often have to endure a battery of tests, and physicians don’t always get the diagnosis right the first time. 

Scientists say the answers may be in the genes. Distinct duplications or deletions in the genome, known as copy number variation (CNV), are associated with neurological disorders, including ADHD. Based on previous studies, ADHD is more likely caused or impacted by a network of underlying pathways as opposed to a single gene variant. Artificial intelligence (AI) has the potential to detect these pathways. However, these models have yet to be established in the context of ADHD.

Now, a team of genomics experts from the Children’s Hospital of Philadelphia report that machine learning could help boost the accuracy of current ADHD diagnostic methodologies. Deep-learning methods average a 78 percent accuracy, a step up from conventional techniques that average 50 percent.

The team collected whole-genome sequencing data from over 500 African Americans (a group often underrepresented in existing genetic databases). They then applied multiple layer deep learning algorithms to capture the genetic susceptibility to the disease and the molecular pathways influencing ADHD.

The study was led by Yichun Liu from the Center for Applied Genomics (CAG). Liu said that AI deep learning paired with advanced sequencing techniques stand to benefit ADHD patients greatly. “Combining both together forms a powerful tool for the prediction and diagnosis of complex mental disorders, such as ADHD, especially for toddlers who are too young to be diagnosed,” explained Liu.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 09, 2021
Health & Medicine
Akathisia Awareness: A Closer Look
OCT 09, 2021
Akathisia Awareness: A Closer Look
Content warning: this article talks in-depth about suicide and self-harm. September was Suicide Prevention Month, but ju ...
OCT 25, 2021
Space & Astronomy
Spaceflight Seems to Raise Levels of Circulating Cell-Free Mitochondrial DNA
OCT 25, 2021
Spaceflight Seems to Raise Levels of Circulating Cell-Free Mitochondrial DNA
Spaceflight is being marketed as a tourist opportunity for extremely wealthy people, and lengthy space missions that cou ...
OCT 29, 2021
Technology
New "Dark-Field" X-ray Technology Improves Diagnostic Abilities for Pulmonary Conditions
OCT 29, 2021
New "Dark-Field" X-ray Technology Improves Diagnostic Abilities for Pulmonary Conditions
We’re all familiar with x-rays—they’re a staple in diagnostic technology. The use of x-rays for medica ...
DEC 08, 2021
Clinical & Molecular DX
Scaling Down to Go Big: An Overview of the Lab-on-a-Chip
DEC 08, 2021
Scaling Down to Go Big: An Overview of the Lab-on-a-Chip
By Julianne Davis - Technical Writer and Support Scientist at Biotium The Rise of the Lab-on-a-Chip With the advent of m ...
JAN 07, 2022
Cancer
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
JAN 07, 2022
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
The blood-brain barrier (BBB) describes the complex vasculature network that delivers oxygen and nutrients to the brain. ...
JAN 14, 2022
Clinical & Molecular DX
No, It's Not Just Insulin That Regulates Blood Sugar
JAN 14, 2022
No, It's Not Just Insulin That Regulates Blood Sugar
  In a research breakthrough, scientists have found a hormone secreted by fat cells that plays a similar role to in ...
Loading Comments...